Bank Of Montreal Dr Reddys Laboratories LTD Transaction History

Bank Of Montreal

$191 Billion
Q1 2024

A detailed history of Bank Of Montreal transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Bank Of Montreal holds 5,656 shares of RDY stock, worth $430,138. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,656

Holding current value

$430,138

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$67.36 - $77.59 $380,988 - $438,849	5,656 New	5,656 $414,000
Q3 2022 Nov 10, 2022	SELL	$49.9 - $57.32 $35,578 - $40,869	-713 Reduced 4.59%	14,821 $786,000
Q2 2022 Aug 11, 2022	SELL	$49.62 - $58.13 $191,235 - $224,033	-3,854 Reduced 19.88%	15,534 $868,000
Q1 2022 May 12, 2022	SELL	$48.27 - $65.25 $639,625 - $864,627	-13,251 Reduced 40.6%	19,388 $1.1 Million
Q4 2021 Feb 11, 2022	SELL	$59.5 - $67.25 $39.3 Million - $44.5 Million	-661,279 Reduced 95.3%	32,639 $2.14 Million

Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $26,303 - $32,901	-437 Reduced 0.06%	693,918 $45.4 Million
Q2 2021 Aug 12, 2021	BUY	$62.12 - $74.2 $43.1 Million - $51.5 Million	694,355 New	694,355 $51.1 Million

Others Institutions Holding RDY

# of Institutions

242

Shares Held

23.6M

Call Options Held

25.2K

Put Options Held

8.5K

Black Rock Inc. New York, NY

2.18M
Shares

$166 Million
0.0% of portfolio
Royal Bank Of Canada Toronto, A6

2.16M
Shares

$165 Million
0.04% of portfolio
Robeco Institutional Asset Management B.V.

1.97M
Shares

$150 Million
0.32% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.93M
Shares

$147 Million
0.22% of portfolio
Goldman Sachs Group Inc New York, NY

1.56M
Shares

$119 Million
0.02% of portfolio

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account